Karolinska Institute’s oncology spinout Aprea Therapeutics has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Unternehmertum’s VC affiliate co-led the deal for i2x, which offers an enhanced speech recognition product that provides automated coaching tips to improve business phone calls.

Touchstone Innovations-backed Cambridge Communication System has received $10m in a funding round that included a $5m commitment from Adtran.

University of Birmingham and Aston University have deepened their relationship with Warwick-operated Minerva to start a syndicate targeting businesses in the West Midlands.

Satt Sud-Est has licensed Yukin Therapeutics to commercialise patents originating from several French institutions on the back of inventions from regional research hub Canceropôle Provence-Alpes-Côte d'Azur.

Charles Conn and Patrick Pichette will join Oxford Sciences Innovation to become chief executive and chairman, respectively, with founder Dave Norwood retiring.

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.

The MIT-founded manufacturing app development spinout has now received more than $31m from investors including Vertex Ventures US, Pitango, NEA and C4 Ventures.

NIH will provide $3.5m to establish a human health-focused accelerator in five US states, with space for five biotech projects in its initial cohort.